| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 02/20/1997 | WO1997005859A2 Use of alicyclic diamines as immunomodulators |
| 02/20/1997 | WO1997005780A1 Regulation of alzheimer's disease related proteins and uses thereof |
| 02/20/1997 | DE19531936A1 Kombinationspräparat zur Kontrazeption, Kits diese enthaltend und eine Methode diese verwendend Combination product for contraception, kits containing them and a method using these |
| 02/20/1997 | DE19530884A1 Verwendung von Prostan-Derivaten sowie deren Kombination mit Antibiotika zur Behandlung von bakteriellen Infektionen Use of prostane derivatives and their combination with antibiotics to treat bacterial infections |
| 02/20/1997 | CA2229044A1 Recombinant c-proteinase and processes, methods and uses thereof |
| 02/20/1997 | CA2229024A1 Use of fluconazole for inhibiting the growth of cancers |
| 02/20/1997 | CA2228689A1 Use of alicyclic diamines as immunomodulators |
| 02/20/1997 | CA2228620A1 Treatment of ocular inflammatory conditions with interleukin-10 |
| 02/20/1997 | CA2228503A1 Use of griseofulvin for inhibiting the growth of cancers |
| 02/20/1997 | CA2228386A1 Food product and its manufacturing method |
| 02/20/1997 | CA2228314A1 Use of pde inhibitors in the manufacture of a medicament for the treatment of bladder diseases |
| 02/20/1997 | CA2225647A1 Regulation of alzheimer's disease related proteins and uses thereof |
| 02/19/1997 | EP0758681A2 Inhibiting transformation of cells having elevated purine metabolic enzyme activity |
| 02/19/1997 | EP0758245A1 Use of spiramycin for treating gastrointestinal disorders caused by h. pylori |
| 02/19/1997 | EP0758233A1 Pde iv inhibitors for treating multiple sclerosis |
| 02/19/1997 | EP0758232A1 Methods for modulating t cell responses by manipulating intracellular signal transduction |
| 02/19/1997 | EP0758228A1 Effective dosage form for antiepileptic drugs |
| 02/19/1997 | EP0491878B1 Compositions for the inhibition of protein hormone formation and uses thereof |
| 02/19/1997 | EP0485431B1 Partial agonists of the strychnine insensitive glycine modulatory site of the n-methyl-d-aspartate receptor complex as neuropsychopharmacological agents |
| 02/19/1997 | CN1143358A Benzamide analogs, useful as parp (ADP-ribosyltransferase, ADRPT) DNA repair enzyme inhibitors |
| 02/19/1997 | CN1143321A Treatment of obsessive-compulsive disorders with 5-HT2 antagonists |
| 02/19/1997 | CN1142945A Medcine for curing cerebrovascular disturbance with psychonosema |
| 02/18/1997 | US5604260 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2 |
| 02/18/1997 | US5604116 Interleukin-3 (IL-3) multiple mutation polypeptides, recombinant production of the same, and corresponding therapeutic methods |
| 02/18/1997 | US5604094 Receptor-type phosphotyrosine phosphatase-β |
| 02/18/1997 | US5603959 Non-steroidal anti-inflammatory drug linked with unsaturated fatty acid or alcohol; cytoprotective agents, side effect reduction |
| 02/18/1997 | US5603943 Physiologically active substance homogeneously dispersed in and adsorbed on polyvalent metal carrier of specified particle size |
| 02/13/1997 | WO1997005285A2 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | WO1997005252A2 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
| 02/13/1997 | WO1997005241A2 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | WO1997005239A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 02/13/1997 | WO1997005195A1 Method of detecting lung disease |
| 02/13/1997 | WO1997005169A1 Ha-2 antigenic peptide |
| 02/13/1997 | WO1997004808A1 Compositions containing analgesics and antihistamines and methods for treating respiratory disorders |
| 02/13/1997 | WO1997004807A1 Methods for treatment of allergic asthma |
| 02/13/1997 | WO1997004780A2 Pain-alleviating drug composition and method for alleviating pain |
| 02/13/1997 | WO1997004768A1 Non-ionic surfactant vesicles as therapeutic agent |
| 02/13/1997 | WO1997004765A1 INHIBITION OF CoA-INDEPENDENT TRANSACYLASE AND APOPTOSIS |
| 02/13/1997 | WO1997004760A1 Use of agonists or antagonists of p2 purinoceptors for the prevention of glutamate-evoked cytotoxicity |
| 02/13/1997 | WO1997004668A2 Two-stage preparation |
| 02/13/1997 | WO1996040128A3 Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof |
| 02/13/1997 | WO1996032133A3 Conjugate for treating inflammatory, infectious and/or skin diseases |
| 02/13/1997 | WO1996002240A3 Use of inhibitors of human s-cd23 |
| 02/13/1997 | DE19529102A1 Verwendung von PDE-Inhibitoren bei der Behandlung von Harnblasenerkrankungen Use of PDE inhibitors in the treatment of urinary bladder diseases |
| 02/13/1997 | CA2228298A1 Non-ionic surfactant vesicles as therapeutic agent |
| 02/13/1997 | CA2227958A1 Compositions containing analgesics and antihistamines and methods for treating respiratory disorders |
| 02/13/1997 | CA2227769A1 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | CA2227694A1 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | CA2227327A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 02/13/1997 | CA2226892A1 Method of detecting lung disease |
| 02/13/1997 | CA2226624A1 Methods for treatment of allergic asthma |
| 02/13/1997 | CA2224909A1 Ha-2 antigenic peptide |
| 02/13/1997 | CA2224293A1 Use of agonists or antagonists of p2 purinoceptors for the prevention of glutamate-evoked cytotoxicity |
| 02/13/1997 | CA2200606A1 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
| 02/12/1997 | EP0758021A2 Method for determining the therapeutic activity of metalloproteinase inhibitor compounds, new inhibitor compounds, and the therapeutic use thereof |
| 02/12/1997 | EP0757716A1 Dna encoding bradykinin b 1? receptor |
| 02/12/1997 | EP0757558A1 Screening methods for integumental inflammation modulating agents |
| 02/12/1997 | EP0757555A1 A method for sustained and extended corneal analgesia |
| 02/12/1997 | CN1142768A Use of PLA2 inhibitors as treatment for Alzheimer's disease |
| 02/11/1997 | US5602183 Diaper dermatitis; mixture of antiinflammatory agent andpyruvate compound, antioxidant and fatty acids |
| 02/11/1997 | US5602150 Treatment of central nervous system disorders associated with psychotic behavior and dementia with a combination of neuroleptic drugs and taurine, or derivatives thereof, to prevent the development of tardive dyskinesia |
| 02/11/1997 | US5602024 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof |
| 02/11/1997 | US5601981 Methods for determining and agents for modulating cellular redox potential and genotoxic states |
| 02/11/1997 | US5601848 Administering bismuth compound |
| 02/11/1997 | US5601838 Method for treating pain associated with herpes-zoster and post-herpetic neuralgia |
| 02/06/1997 | WO1997004312A1 Compounds and methods related to parathyroid hormone-like protein |
| 02/06/1997 | WO1997004004A1 CYSTEINE PROTEASE INHIBITORS FOR USE IN TREATMENT OF IgE MEDIATED ALLERGIC DISEASES |
| 02/06/1997 | WO1997003998A1 Modulators of the function of fas receptors and other proteins |
| 02/06/1997 | WO1997003699A1 Use of hyaluronic acid and a nsaid for the manufacture of a medicament for the treatment of mucosal diseases |
| 02/06/1997 | WO1997003695A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein |
| 02/06/1997 | WO1997003684A1 Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment |
| 02/06/1997 | WO1997003682A1 Method for treating cancers using 6-[3-[1-adamantyl]-4-hydroxyphenyl] |
| 02/06/1997 | WO1997003678A1 Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts |
| 02/06/1997 | WO1997003671A1 Composition comprising d-threo-methylphenidate and another drug |
| 02/06/1997 | WO1997003670A1 Paroxetine controlled release compositions |
| 02/06/1997 | WO1997003666A1 Agent for suppressing tumour growth |
| 02/06/1997 | WO1997003662A1 Pharmaceutical composition of l-dopa ethyl ester |
| 02/06/1997 | WO1997003659A1 Use of a non-steroidal anti-inflammatory drug for topical and systemic treatment of acute and chronic polypoid rhinosinusitis |
| 02/06/1997 | WO1996035415A3 Use of sesquiterpenes for inhibiting oxidative enzymes |
| 02/06/1997 | CA2227334A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein |
| 02/06/1997 | CA2227208A1 Pharmaceutical composition of l-dopa ethyl ester |
| 02/06/1997 | CA2227198A1 Cysteine protease inhibitors for use in treatment of ige mediated allergic diseases |
| 02/06/1997 | CA2227034A1 Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts |
| 02/06/1997 | CA2223489A1 Method for treating cancer using ahpn |
| 02/05/1997 | EP0756868A2 Aerosol compositions |
| 02/05/1997 | EP0756862A1 Use of bradykinine antagonist in a cosmetic, pharmaceutical or dermatological composition and the composition obtained |
| 02/05/1997 | EP0756595A1 Substituted 1,3-oxathiolanes with antiviral properties |
| 02/05/1997 | EP0756487A1 Method for implanting encapsulated cells in a host |
| 02/05/1997 | EP0756477A1 Methods for phototherapeutic treatment of proliferative skin diseases |
| 02/05/1997 | EP0527879B1 Synergistic therapeutic compositions and methods |
| 02/04/1997 | US5599991 Esylate and sulfate salts of R(+)-N-propargyl-1-aminoindan |
| 02/04/1997 | US5599844 Administering agent to elevate level of transforming growth factor beta |
| 02/04/1997 | US5599843 Visibly reducing wrinkles by applying mixtures containing 2-hydroxy-2-phenyl-propionic acid |
| 02/04/1997 | US5599794 Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic |
| 02/04/1997 | US5599552 Biodegradable polymer composition |
| 02/04/1997 | US5599535 Administering a non-steroidal antiinflammatory agent preventing cell lose in eye disorders |
| 02/04/1997 | US5599388 Acid resistant calcium carbonate composition containing an aluminum salt, uses therefor and processes for its production |
| 02/04/1997 | CA1338888C Matrix with immunomodulating activity |
| 01/30/1997 | WO1997003086A1 Early onset alzheimer's disease gene and gene products |
| 01/30/1997 | WO1997002840A1 Immunovectors for the intracellular and intranuclear transport |